Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease

SHP-201Positive

AI Analysis

Summary

Shape Therapeutics received a research grant from The Michael J. Fox Foundation to advance SHP-201, an intravenously delivered gene therapy designed to reduce alpha-synuclein for Parkinson's Disease treatment. The grant supports IND-enabling studies for the one-time gene therapy.

Outcome Details

Research grant awarded to support IND-enabling studies

Importance:4/10

Sentiment:

0.60

gene therapyParkinson's Diseasealpha-synucleinintravenous deliveryIND-enablinggrant funding

Related Companies

$BNN.DE $DRTSW

Read the original article

Published by GlobeNewswire Clinical Studies on July 29, 2026 10:00 AM

Read Original